We are crossing the country virtually to raise awareness symbolising our commitment to bringing treatments to every Australian family impacted by Angelman syndrome, in Australia. Registration starts at $20, all you have to do is move (run, walk, bike, swim) and log it on Strava!

Neuren is a Melbourne-based company at the forefront of efforts to develop effective treatments for rare, paediatric neurodevelopmental disorders, they plan to initiate an Australian clinical trial in Angelman later in 2021. 

FAST Australia are committed to funding and establishing an Angelman syndrome Centre of Excellence to deliver a uniform standard of care across Australia and create infrastructure for clinical trials.